Portal de Periódicos da CAPES

The neutrophil in transfusion medicine

1994; Wiley; Volume: 34; Issue: 7 Linguagem: Inglês

10.1046/j.1537-2995.1994.34794330020.x

1537-2995

Douglas W. Huestis, Leslie Glasser,

Blood transfusion and management

TransfusionVolume 34, Issue 7 p. 630-646 The neutrophil in transfusion medicine D.W. Huestis MD, Corresponding Author D.W. Huestis MD Professor Emeritus Sections of Transfusion Medicine and Hematopathology, Department of Pathology, University of Arizona College of Medicine, Tucson, Arizona.Department of Pathology, University of Arizona College of Medicine, 1501 North Campbell Avenue, Tucson, AZ 85724.Search for more papers by this authorL. Glasser, L. Glasser Sections of Transfusion Medicine and Hematopathology, Department of Pathology, University of Arizona College of Medicine, Tucson, Arizona. Lewis Glasser, MD, Professor, Department of Pathology, University of Arizona College of Medicine.Search for more papers by this author D.W. Huestis MD, Corresponding Author D.W. Huestis MD Professor Emeritus Sections of Transfusion Medicine and Hematopathology, Department of Pathology, University of Arizona College of Medicine, Tucson, Arizona.Department of Pathology, University of Arizona College of Medicine, 1501 North Campbell Avenue, Tucson, AZ 85724.Search for more papers by this authorL. Glasser, L. Glasser Sections of Transfusion Medicine and Hematopathology, Department of Pathology, University of Arizona College of Medicine, Tucson, Arizona. Lewis Glasser, MD, Professor, Department of Pathology, University of Arizona College of Medicine.Search for more papers by this author First published: July 1994 https://doi.org/10.1046/j.1537-2995.1994.34794330020.xCitations: 21 Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 Metchnikoff E. Immunity in infective diseases. New York: Johnson Reprint Corporation, 1968. 2 Colebrook L. Almroth Wright: provocative doctor and thinker. London: Heinemann, 1954. 3 Shaw GB. The doctor's dilemma, Act I. 1906. 4 Vincent PC. The measurement of granulocyte kinetics. Br J Haematol 1977; 36: 1–4. 5 Dancey JT, Deubeleiss KA, Harker LA, Finch CA. Neutrophil kinetics in man. J Clin Invest 1976; 58: 705–15. 6 Marsh JC, Boggs DR, Cartwright GE, Wintrobe MM. Neutrophil kinetics in acute infection. J Clin Invest 1967; 46: 1943–53. 7 Athens JW, Haab OP, Raab SO, et al. Leukokinetic studies. XI. Blood granulocyte kinetics in polycythemia vera, infection, and myelofibrosis. J Clin Invest 1965; 44: 778–88. 8 Athens JW, Haab OP, Raab SO, et al. Leukokinetic studies. IV. The total blood, circulating and marginal granulocyte pools and the granulocyte turnover rate in normal subjects. J Clin Invest 1961; 40: 989–95. 9 Bodey GP, Buckley M, Sathe YS, Freireich EJ. Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. Ann Intern Med 1966; 64: 328–40. 10 Sickles EA, Greene WH, Wiernik PH. Clinical presentation of infection in granulocytopenic patients. Arch Intern Med 1975; 135: 715–9. 11 Bridges RA, Berendes H, Good RA. A fatal granulomatous disease of childhood. The clinical, pathological, and laboratory features of a new syndrome. Am J Dis Child 1959: 97: 387–408. 12 Schiffer CA, Buchholz DH, Aisner J, Betts SW, Wiernik PH. Clinical experience with transfusion of granulocytes obtained by continuous flow filtration leukopheresis. Am J Med 1975; 58: 373–81. 13 Higby DJ, Yates JW, Henderson ES, Holland JF. Filtration leukapheresis for granulocyte transfusion therapy. N Engl J Med 1975; 292: 761–6. 14 Lehrer RI, Ganz T, Selsted ME, Babior BM, Curnutte JT. Neutrophils and host defense. Ann Intern Med 1988; 109: 127–42. 15 Alavi JB, Root RK, Djerassi I, et al. A randomized trial of granulocyte transfusions for infection in acute leukemia. N Engl J Med 1977; 296: 706–11. 16 Lehrer RI, Cline MJ. Leukocyte myeloperoxidase deficiency and disseminated candidiasis: the role of myeloperoxidase in resistance to Candida infection. J Clin Invest 1969; 48: 1478–88. 17 Lehrer RI, Cline MJ. Interaction of Candida albicans with human leukocytes and serum. J Bacterid 1969; 98: 996–1004. 18 Epstein RB, Andersen BR. The pathophysiologic effects of granulocyte transfusion. In: CF Högman, K Lindahl-Kiesling, H Wigzell, eds. Blood leukocyte function and use in therapy. Stockholm: Almqvist and Wiksell, 1977: 60–3. 19 Douglas RG, Alford RH, Cate TR, Couch RB. The leukocyte response during viral illness in man. Ann Intern Med 1966: 521–30. 20 Feigin RD, Shackelford PG. Value of repeat lumbar puncture in the differential diagnosis of meningitis. N Engl J Med 1973; 289: 571–4. 21 Stevens DA, Ferrington RA, Jordan GW, Merigan TC. Cellular events in zoster vesicles: relation to clinical course and immune parameters. J Infect Dis 1975; 131: 509–15. 22 Klebanoff SJ, Coombs RW. Viricidal effect of polymorphonuclear leukocytes on human immunodeficiency virus-1. J Clin Invest 1992; 89: 2014–7. 23 McFarlane PS, Spiers AL, Sommerville RG. Fatal granulomatous disease of childhood and benign lymphocytic infiltration of the skin (congenital dysphagocytosis). Lancet 1967; 1: 408–10. 24 Faden H, Ogra P. Neutrophils and antiviral defense. Pediatr Infect Dis 1986; 5: 86–92. 25 Abramson JS, Mills EL. Depression of neutrophil function induced by viruses and its role in secondary microbial infections. Rev Infect Dis 1988; 10: 326–41. 26 Springer T. Adhesion receptors of the immune system. Nature 1990; 346: 425–34. 27 Glasser L. Functional considerations of granulocyte concentrates used for clinical transfusions. Transfusion 1979; 19: 1–6. 28 Aisner J, Schiffer CA, Wiernik PH. Granulocyte transfusions: evaluation of factors influencing results and a comparison of filtration and intermittent centrifugation leukapheresis. Br J Haematol 1978; 38: 121–9. 29 Cline MJ. Drugs and phagocytes. N Engl J Med 1974; 291: 1187–8. 30 Glasser L, Huestis DW, Jones JF. Functional capabilities of steroid-recruited neutrophils harvested for clinical transfusion. N Engl J Med 1977; 297: 1033–6. 31 Huestis DW, Bove JR, Busch S. Practical blood transfusion. 3rd ed. Boston: Little, Brown, 1981: 318–35. 32 Tullis JL. Separation and purification of leukocytes and platelets. Blood 1952; 7: 891–6. 33 Tullis JL, Tinch RJ, Gibson JG II, Baudanza P. A simplified centrifuge for the separation and processing of blood cells. Transfusion 1967; 7: 232–42. 34 Tullis JL, Eberle WG, Baudanza P, Tinch R. Platelet-pheresis. Description of a new technic. Transfusion 1968; 8: 154–64. 35 Szymanski IO, Kliman A. Transfusions of platelets and white cells. NY St J Med 1973; 73: 1859–63. 36 Tullis JL, Tinch RJ, Baudanza P, et al. Plateletpheresis in a disposable system. Transfusion 1971; 11: 368–77. 37 Freireich EJ, Levin RH, Whang J, Carbone PP, Morse EE. The function and fate of transfused leukocytes from donors with chronic myelocytic leukemia in leukopenic recipients. Ann N Y Acad Sci 1964; 113: 1081–9. 38 Yankee RA, Freireich EJ, Carbone PP, Frei E III. Replacement therapy using normal and chronic myelogenous leukemic leukocytes. Blood 1964; 24: 844–5. 39 Morse EE, Freireich EJ, Carbone PP, Bronson W, Frei E III. The transfusion of leukocytes from donors with chronic myelocytic leukemia to patients with leukopenia. Transfusion 1966; 6: 183–92. 40 Vallejos CS, McCredie KB, Brittin GM, Freireich EJ. Biological effects of repeated leukapheresis of patients with chronic myelogenous leukemia. Blood 1973; 42: 925–33. 41 Schiffer CA, Aisner J, Dutcher JP, Wiemik PH. Sustained posttransfusion granulocyte count increments following transfusion of leukocytes obtained from donors with chronic myelogenous leukemia. Am J Hematol 1983; 15: 65–74. 42 Schiffer CA. Granulocyte transfusions: an overlooked therapeutic modality. Transfus Med Rev 1990; 4: 2–7. 43 Freireich EJ, Judson G, Levin RH. Separation and collection of leukocytes. Cancer Res 1965; 25: 1516–20. 44 Freireich EJ. Leukocyte collection and transfusion: a historical perspective. In: JM Goldman, RM Lowenthal, eds. Leukocytes. Separation collection and transfusion. London: Academic Press, 1975: xxvii–xxxvi. 45 Graw RG Jr, Herzig G, Perry S, Henderson ES. Normal granulocyte transfusion therapy: treatment of septicemia due to gram-negative bacteria. N Engl J Med 1972; 287: 367–71. 46 Dale DC, Reynolds HY, Pennington JE, Elin RJ, Pitts TW, Graw RG Jr. Granulocyte transfusion therapy of experimental Pseudomonas pneumonia. J Clin Invest 1974; 54: 664–71. 47 Debelak KM, Epstein RB, Andersen BR. Granulocyte transfusions in leukopenic dogs: in vivo and in vitro function of granulocytes obtained by continuous-flow filtration leukopheresis. Blood 1974; 43: 757–66. 48 Epstein RB, Waxman FJ, Bennett BT, Andersen BR. Pseudomonas septicemia in neutropenic dogs. I. Treatment with granulocyte transfusions. Transfusion 1974; 14: 51–7. 49 Appelbaum FR, Bowles CA, Makuch RW, Deisseroth AB. Granulocyte transfusion therapy of experimental Pseudomonas septicemia: study of cell dose and collection technique. Blood 1978; 52: 323–31. 50 FK Widmann, ed. Standards for blood banks and transfusion services. 15th ed. Bethesda: American Association of Blood Banks, 1993. 51 Poon A, Wilson S. Simple manual method for harvesting granulocytes. Transfusion 1980; 20: 71–4. 52 Stong CL. The amateur scientist. Sci Am 1975; 23(12): 120–2. 53 Tullis JL, Surgenor DM, Tinch RJ, et al. New principle of closed system centrifugation. Science 1956; 124: 792–7. 54 Mishler JM IV. Pharmacology of hydroxyethyl starch. Oxford: Oxford University Press, 1982. 55 Mishler JM, Hester JP, Huestis DW, Rock GA, Strauss RG. Dosage and scheduling regimens for erythrocyte-sedimenting macromolecules. J Clin Apheresis 1983; 1: 130–43. 56 Maguire LC, Strauss RG, Koepke JA, et al. The elimination of hydroxyethyl starch from the blood of donors experiencing single or multiple intermittent-flow centrifugation leukapheresis. Transfusion 1981; 21: 347–53. 57 Strauss RG, Hester JP, Vogler WR, et al. A multicenter trial to document the efficacy and safety of a rapidly excreted analog of hydroxyethyl starch for leukapheresis with a note on steroid stimulation of granulocyte donors. Transfusion 1986; 26: 258–64. 58 Strauss RG, Villhauer PJ, Imig KM, Eckermann I, Gupta SD, Thomson DS. Selecting the optimal dose of low-molecular-weight hydroxyethyl starch (Pentastarch) for granulocyte collection. Transfusion 1987; 27: 350–2. 59 Benbunan M, Bussel A, Reviron J, Boiron M, Bernard J. Les transfusions de granulocytes normaux prélevés sur séparateur de cellules. Résultats techniques et cliniques. Nouv Rev Fr Hématol 1973; 13: 469–86. 60 Lowenthal RM, Park DS. The use of dextran as an adjunct to granulocyte collection with the continuous-flow blood cell separator. Transfusion 1975; 15: 23–7. 61 Huestis DW. Use of Dextran 75 as a macromolecular agent in centrifugal leukapheresis. Transfusion 1977; 17: 156–8. 62 Huestis DW, Loftus TJ, Gilcher R, et al. Modified fluid gelatin. An alternative macromolecular agent for centrifugal leukapheresis. Transfusion 1985; 25: 343–8. 63 Huestis DW, White RF, Price MJ, Inman M. Use of hydroxyethyl starch to improve granulocyte collection in the Latham blood processor. Transfusion 1975; 15: 559–64. 64 Vogler WR, Lawson DH, Moffitt S, Mallard HE, Winton EF. Collection and transfusion of granulocytes from stimulated donors. In: CH Mielke, ed. Apheresis: development, applications, and collection procedures. New York: Alan R. Liss, 1981: 29–40. 65 Soderlund I, Engstedt L, Paleus S, Unger P. Induction of leukocytosis by means of hydrocortisone and/or muscular exercise. In: JM Goldman, RM Lowenthal, eds. Leukocytes: separation, collection and transfusion. London: Academic Press, 1975: 97–103. 66 Hinckley MH, Huestis DW. Premedication for optimal granulocyte collection. Plasma Ther 1981; 2: 149–52. 67 Mishler JM IV. The effects of corticosteroids on mobilization and function of neutrophils. Exp Hematol 1977; 5(Suppl): 15–32. 68 McCredie KB, Freireich EJ, Hester JP, Vallejos C. Increased granulocyte collection with the blood cell separator and the addition of etiocholanolone and hydroxyethyl starch. Transfusion 1974; 14: 357–64. 69 Higby DJ, Mishler JM, Rhomberg W, Nicora RW, Holland JF. The effect of a single or double dose of dexamethasone on granulocyte collection with the continuous flow centrifuge. Vox Sang 1975; 28: 243–8. 70 Bensinger WI, Price TH, Dale DC, et al. The effects of daily recombinant human granulocyte colony-stimulating factor administration on normal granulocyte donors undergoing leukapheresis. Blood 1993; 81: 1883–8. 71 Strauss RG. Therapeutic granulocyte transfusions in 1993. Blood 1993; 81: 1675–8. 72 Caspar CB, Seger RA, Burger J, Gmür J. Effective stimulation of donors for granulocyte transfusions with recombinant methionyl granulocyte colony-stimulating factor. Blood 1993; 81: 2866–71. 73 Loftus TJ, White RF, Huestis DW. Leukapheresis: increasing the granulocyte yield with the Fenwal CS-3000. J Clin Apheresis 1983; 1: 109–14. 74 Djerassi I. Filtration leukopheresis for the separation and concentration of transfusable amounts of normal human granulocytes. J Med (Basel) 1970; 1: 358–64. 75 Higby DJ, Freeman A, Henderson ES, Sinks L, Cohen E. Granulocyte transfusions in children using filter-collected cells. Cancer 1976; 38: 1407–13. 76 Maguire LC, Henriksen RA, Strauss RG, et al. Function and morphology of platelets produced for transfusion by intermittent-flow centrifugation plateletpheresis or combined platelet-leukapheresis. Transfusion 1981; 21: 118–23. 77 Schiffer CA, Aisner J, Schmukler M, Whitaker CL, Wolff JH. The effect of hydroxyethyl starch on in vitro platelet and granulocyte function. Transfusion 1975; 15: 473–5. 78 Moser R, Meuret G, Senn HJ. Funktionelle Veranderungen der Neutrophilen und Monozyten durch Konditionierung und Filtrations Leukapherese? Blut 1980; 41: 347–57. 79 Higby DJ, Burnett D. Granulocyte transfusions: current status. Blood 1980; 55: 2–8. 80 Robinson AE. White cell concentrate therapy. In: JD Cash, ed. Progress in transfusion medicine, vol 1. Edinburgh: Churchill Livingstone, 1986: 31–59. 81 Steigbigel RT, Baum J, MacPherson JL, Nusbacher J. Granulocyte bactericidal capacity and chemotaxis as affected by continuous-flow centrifugation and filtration leukapheresis, steroid administration, and storage. Blood 1978; 52: 197–209. 82 Ts'ao C, Ruder EA. Ultrastructural damage of leukocytes procured by the Leukopak: vulnerability of leukocytes to mechanical injury. Transfusion 1976; 16: 336–44. 83 Huestis DW. Technical aspects of cell collection—donor considerations. Clin Oncol 1983; 2: 529–47. 84 Djerassi I. Gravity leucapheresis—a new method for collection of transfusable granulocytes. Exp Hematol 1977; 5(Suppl): 139–43. 85 Aisner J, Schiffer CA, Hedmann S, Wiernik PH. Gravity leukapheresis—a simple method of leukocyte collection for transfusion or in vitro study. Leuk Res 1979; 3: 1–5. 86 Ambinder EP, Button GR, Cheung T, Goldberg JD, Holland JF. Filtration versus gravity leukapheresis in febrile granulocytopenic patients: a randomized prospective trial. Blood 1981; 57: 836–41. 87 Aisner J, Schiffer CA, Daly PA, Buchholz DH. Evaluation of gravity leukapheresis and comparison with intermittent centrifugation leukapheresis. Transfusion 1981; 21: 100–6. 88 Huestis DW. Risks and safety practices in hemapheresis procedures. Arch Pathol Lab Med 1989; 113: 273–8. 89 Dutcher JP, Aisner J, Hogge DE, Schiffer CA. Donor reaction to hydroxyethyl starch during granulocytapheresis. Transfusion 1984; 24: 66–7. 90 Bode U, Deisseroth AB. Donor toxicity in granulocyte collections: association of lichen planus with the use of hydroxyethyl starch leukapheresis. Transfusion 1981; 21: 83–5. 91 Newman RS, Barr RJ, Ocariz JA, Kaplan HS. Does hydroxyethyl starch cause lichen planus? Lichen planus in a long-time routine blood donor never exposed to hydroxyethyl starch. Transfusion 1983; 23: 531–2. 92 Rock G, Wise P. Plasma expansion during granulocyte procurement: cumulative effects of hydroxyethyl starch. Blood 1979; 53: 1156–63. 93 Strauss RG, Koepke JA. Chemistry, pharmacology, and donor effects of hydroxyethyl starch as used during leukapheresis. Plasma Ther 1980; 1(3): 35–44. 94 Sandler SG, Nusbacher J. Health risks of leukapheresis donors. Haematologia 1982; 15: 57–69. 95 Hammerschmidt DE, Craddock PR, McCullough F, et al. Complement activation and pulmonary leukostasis during nylon fiber filtration leukapheresis. Blood 1978; 51: 721–30. 96 Nusbacher J, Rosenfeld SI, MacPherson JL, Thiem PA, Leddy JP. Nylon fiber leukapheresis: associated complement component changes and granulocytopenia. Blood 1978; 51: 359–65. 97 Dahlke MB, Shah SL, Sherwood WC, Shafer AW, Brownstein PK. Priapism during filtration leukapheresis. Transfusion 1979; 19: 482–6. 98 Glasser L, Lane TA, McCullough JJ, Price TH. Neutrophil concentrates: functional considerations, storage, and quality control. J Clin Apheresis 1983; 1: 179–84. 99 Glasser L. Effects of storage on normal neutrophils collected by discontinuous-flow centrifugation leukapheresis. Blood 1977; 50: 1145–50. 100 Lane TA, Windle B. Granulocyte concentrate function during preservation: effect of temperature. Blood 1979; 54: 216–25. 101 McCullough J, Weiblen BJ, Quie PG. Chemotactic activity of human granulocytes in various anticoagulants. J Lab Clin Med 1974; 84: 902–6. 102 McCullough J, Weiblen BJ, Fine D. Effects of storage of granulocytes on their fate in vivo. Transfusion 1983; 23: 20–4. 103 Lane TA, Lamkin GE. Chemotaxis receptor cycling in fresh and stored granulocytes. Transfusion 1988; 28: 362–7. 104 Palm SL, Furcht LT, McCullough J. Effects of temperature and duration of storage on granulocyte adhesion, spreading, and ultrastructure. Lab Invest 1981; 45: 82–8. 105 McCullough J, Weiblen BJ, Peterson PK, Quie PG. Effect of temperature on granulocyte preservation. Blood 1978; 52: 301–10. 106 Contreras TJ, Jemionek JF, French JE, Hartwig VM, Walden DA. Liquid preservation of highly purified human granulocytes. Cryobiology 1980; 17: 243–51. 107 Lane TA, Lamkin GE. The effects of storage on degranulation by human neutrophils. Transfusion 1985; 25: 155–61. 108 McCullough J, Carter SJ, Quie PG. Effects of anticoagulants and storage on granulocyte function in bank blood. Blood 1974; 43: 207–17. 109 Patrone F, Dallegre F, Brewer F, Sacchetti C. Effects of irradiation and storage on granulocytes harvested by continuous-flow centrifugation. Exp Hematol 1979; 7: 131–6. 110 Glasser L. The molecular pathobiology of stored neutrophils. Plasma Ther Transfus Technol 1988; 9: 295–302. 111 Glasser L, Fiederlein RL. Functional differentiation of normal human neutrophils. Blood 1987; 69: 937–44. 112 McCullough JJ, Weiblen BJ. The relationship of granulocyte ATP to chemotactic response during storage. Transfusion 1979; 19: 764–7. 113 Glasser L, Fiederlein RL, Huestis DW. Granulocyte concentrates. Glucose concentrations and glucose utilization during storage at 22°C. Transfusion 1985; 25: 68–9. 114 Glasser L, Fiederlein RL. The effect of platelets and red cells on granulocytes stored at 22°C. Transfusion 1984; 24: 310–5. 115 Lane TA, Lamkin GE. Hydrogen ion maintenance improves the chemotaxis of stored granulocytes. Transfusion 1984; 24: 231–7. 116 Glasser L, Fiederlein RL, Huestis DW. Liquid preservation of human neutrophils stored in synthetic media at 22°C: controlled observations on storage variables. Blood 1985; 66: 267–72. 117 Graham-Pole J, Davie M, Willoughby ML. Cryopreservation of human granulocytes in liquid nitrogen. J Clin Pathol 1977; 30: 758–62. 118 Lane TA. Granulocyte storage. Transfus Med Rev 1990; 4: 23–34. 119 Brach MA, de Vos S, Grass HJ, Herrmann F. Prolongation of survival of human polymorphonuclear neutrophils by granulocyte-macrophage colony-stimulating factor is caused by inhibition of programmed cell death. Blood 1992; 80: 2920–4. 120 Colotta F, Re F, Polentarutti N, Sozzani S, Mantovani A. Modulation of granulocyte survival and programmed cell death by cytokines and bacterial products. Blood 1992; 80: 2012–20. 121 Klebanoff SJ, Olszowski S, van Voorhis WC, Ledbetter JA, Waltersdorph AM, Schlechte KG. Effects of Γ-interferon on human neutrophils: protection from deterioration on storage. Blood 1992; 80: 225–34. 122 Herzig RH, Herzig GP, Graw RG Jr, Bull MI, Ray KK. Successful granulocyte transfusion therapy for gram-negative septicemia. A prospective randomized controlled study. N Engl J Med 1977; 296: 701–5. 123 Higby DJ, Henderson ES, Holland JF. Granulocyte transfusion therapy: a randomized clinical trial. In: JM Goldman, RM Lowenthal, eds. Leucocytes: separation, collection and transfusion. New York: Academic Press, 1975: 307–15. 124 Fortuny IE, Bloomfield CD, Hadlock DC, Goldman A, Kennedy BJ, McCullough JJ. Granulocyte transfusion: a controlled study in patients with acute nonlymphocytic leukemia. Transfusion 1975; 15: 548–58. 125 Vogler WR, Winton EF. A controlled study of the efficacy of granulocyte transfusions in patients with neutropenia. Am J Med 1977; 63: 548–55. 126 Winston DJ, Ho WG, Gale RP. Therapeutic granulocyte transfusions for documented infections. A controlled trial in ninety-five infectious granulocytopenic episodes. Ann Intern Med 1982; 97: 509–15. 127 Winton EF, Vogler WR, Glasser L. Dose in granulocyte transfusion. Ann Intern Med 1983; 98: 257. 128 Winton EF, Moffitt S, Vogler WR, et al. Influence of quantity of granulocytes transfused on response. In: WR Vogler, ed. Cytapheresis and plasma exchange: clinical indications. New York: Alan R. Liss, 1982: 75–91. 129 Clift RA, Sanders JE, Thomas ED, Williams B, Buckner CD. Granulocyte transfusions for the prevention of infection in patients receiving bone-marrow transplants. N Engl J Med 1978; 298: 1052–7. 130 Buckner CD, Clift RA, Thomas ED, et al. Early infectious complications in allogeneic marrow transplant recipients with acute leukemia: effects of prophylactic measures. Infection 1983; 11: 243–50. 131 Strauss RG, Connett JE, Gale RP, et al. A controlled trial of prophylactic granulocyte transfusions during initial induction chemotherapy for acute myelogenous leukemia. N Engl J Med 1981; 305: 597–603. 132 Sacher RA, Luban NL, Strauss RG. Current practice and guidelines for the transfusion of cellular blood components in the newborn. Transfus Med Rev 1989; 3: 39–54. 133 Cairo MS. The use of granulocyte transfusion in neonatal sepsis. Transfus Med Rev 1990; 4: 14–22. 134 Christensen RD. Granulocytopoiesis in the fetus and neonate. Transfus Med Rev 1990; 4: 8–13. 135 Strauss RG. Transfusion therapy in neonates. Am J Dis Child 1991; 145: 904–11. 136 Christensen RD, Bradley PP, Rothstein G. The leukocyte left shift in clinical and experimental neonatal sepsis. J Pediatr 1981; 98: 101–5. 137 Christensen RD, Anstall H, Rothstein G. Neutrophil transfusion in septic neutropenic neonates. Transfusion 1982; 22: 151–3. 138 Baley JE, Stork EK, Warkentin PI, Shurin SB. Buffy coat transfusions in neutropenic neonates with presumed sepsis: a prospective, randomized trial. Pediatrics 1987; 80: 712–20. 139 Yomtovian R, Abramson J, Quie P, McCullough J. Granulocyte transfusion therapy in chronic granulomatous disease. Report of a patient and review of the literature. Transfusion 1981; 21: 739–43. 140 Buescher ES, Gallin JI. Leukocyte transfusions in chronic granulomatous disease: persistence of transfused leukocytes in sputum. N Engl J Med 1982; 307: 800–3. 141 Workman RD, Faville RJ, Strate RG, Quie PG, Jager RM, McCullough J. Granulocyte transfusions for patients with severe thermal burns. Transfusion 1978; 18: 142–8. 142 McCullough J, Press C, Clay M, Kline W. Granulocyte serology. A clinical and laboratory guide. Chicago: ASCP Press, 1988: 51–63. 143 Dunstan RA, Simpson MB, Borowitz M. Absence of ABH antigens on neutrophils. Br J Haematol 1985; 60: 651–7. 144 Gaidulis L, Branch DR. Lazar GS, Petz LD. The red cell antigens A, B, D, U, GE, Jk3 and Yta are not detected on human granulocytes. Br J Haematol 1985; 60: 659–68. 145 Graw RG Jr. Goldstein IM, Eyre HJ, Terasaki PI. Histocompatibility testing for leucocyte transfusion. Lancet 1970; 1: 77–8. 146 Goldstein IM, Eyre HJ, Terasaki PI, Henderson ES, Graw RG Jr. Leukocyte transfusions: role of leukocyte alloantibodies in determining transfusion response. Transfusion 1971; 11: 19–24. 147 Appelbaum FR, Trapani RJ, Graw RG Jr. Consequences of prior alloimmunization during granulocyte transfusion. Transfusion 1977; 17: 460–4. 148 Dutcher JP, Schiffer CA, Johnston GS, et al. Alloimmunization prevents the migration of transfused indium-111-labeled granulocytes to sites of infection. Blood 1983; 62: 354–60. 149 McCullough J, Weiblen B, Clay ME, Forstrom L. Effect of leukocyte antibodies on the fate in vivo of Indium-111-labeled granulocytes. Blood 1981; 58: 164–70. 150 Chow HS, Sarpel SC, Epstein RB. Pathophysiology of Candida albicans meningitis in normal, neutropenic, and granulocyte transfused dogs. Blood 1980; 55: 546–51. 151 Ungerleider RS, Appelbaum FR, Trapani RJ, Deisseroth AB. Lack of predictive value of antileukocyte antibody screening in granulocyte transfusion therapy. Transfusion 1979; 19: 90–4. 152 Bux J, Dickmann JO, Stockert U, Mueller-Eckhardt C. Influence of granulocyte antibodies on granulocyte function. Vox Sang 1993; 64: 220–5. 153 Athens JW. Neutrophilic granulocyte kinetics and granulopoiesis. In: AS Gordon, ed. Regulation of hematopoiesis. New York: Appleton-Century-Crofts, 1970: 2; 1143–66. 154 Hersman J, Meyers JD, Thomas ED, Buckner CD, Clift R. The effect of granulocyte transfusions on the incidence of cytomegalovirus infection after allogeneic marrow transplantation. Ann Intern Med 1982; 96: 149–52. 155 Wick MR, Moore SB, Gastineau DA, Hoagland HC. Immunologic, clinical, and pathologic aspects of human graft-versus-host disease. Mayo Clin Proc 1983; 58: 603–12. 156 Dinsmore RE, Straus DJ, Pollak MS, et al. Fatal graft-versus-host disease following blood transfusion in Hodgkin's disease documented by HLA typing. Blood 1980; 55: 831–4. 157 Weiden P. Graft-v-host disease following blood transfusions. Arch Int